Clinical Trials Browser

OTHER_GOV × Azacitidine × Plasma cell × Clear all

NCT00412919 2013-12-16

Study of Azacitidine to Treat Relapsed or Refractory Multiple Myeloma

Phase 2 Terminated

Multiple Myeloma, Recurrence, Neoplasms, Plasma Cell